Symbol: |
YAF2
|
Description: |
YY1 associated factor 2 [Source:HGNC Symbol;Acc:17363]
|
Location: |
Chr12:42550906-42632151[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:162
Gene |
Compound |
Gen_sig |
Exp_pattern |
YAF2 |
CHALCONE ANALOG |
0.017 |
Down |
YAF2 |
1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(6-methyl-2-pyridinyl)ethylidene]hydrazide |
0.015 |
Down |
YAF2 |
CAP 1 hydrochloride |
0.048 |
Down |
YAF2 |
VOBTUSINE, (3E)-HYDROXY- |
0.03 |
Up |
YAF2 |
NSC 373814 |
0.014 |
Down |
YAF2 |
NSC 405789 |
0.019 |
Down |
YAF2 |
NSC 406433 |
0.019 |
Down |
YAF2 |
Neocuproin |
0.045 |
Down |
YAF2 |
NSC 49713 |
0.035 |
Down |
YAF2 |
Camptothecin hemisuccinate sodium salt |
0.028 |
Down |
YAF2 |
NSC 614053 |
0.01 |
Down |
YAF2 |
2-Propen-1-one, 3-(l,3-benzodioxol-5-yl)-1-(1,4-dioxo- 2,6,7-trimethylquinoxalin-3-yl)- |
0.019 |
Up |
YAF2 |
14-FLUORO-4-DEMETHOXYDAUNORUBICIN |
0.043 |
Down |
YAF2 |
ANTINEOPLASTIC-625543 |
0.033 |
Down |
YAF2 |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.043 |
Up |
Expression pattern: Sensitivity / Resistance
Total:11 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:113
Total:8 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:6
Gene |
Gen_transcript |
miRNA |
miR_location |
YAF2 |
ENST00000327791 |
hsa-mir-199a-5p |
Chr19:10928145-10928167[-] |
YAF2 |
ENST00000327791 |
hsa-mir-199a-5p |
Chr1:172113732-172113754[-] |
YAF2 |
ENST00000327791 |
hsa-mir-497-3p |
Chr17:6921257-6921278[-] |
YAF2 |
ENST00000327791 |
hsa-mir-9-3p |
Chr15:89911302-89911323[+] |
YAF2 |
ENST00000327791 |
hsa-mir-9-3p |
Chr1:156390146-156390167[-] |
YAF2 |
ENST00000327791 |
hsa-mir-9-3p |
Chr5:87962684-87962705[-] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|